curvetl curvetr
Contact Us image
header
curvebl curvebr
curvetl curvetr
Member login
Side Menu

Partners

UCL
UPS
UNISI
Erasmus MC
QCMD
C-it

headergif

Erasmus MC

headergif

Erasmus MC (EMC)

The Erasmus MC (EMC) is a 1,320 bed university medical centre situated in Rotterdam, the Netherlands that employs approximately 10.000 people. It provides teaching facilities for approximately 3,500 students, with approximately 200 PhD students gaining their postdoctoral degree in 2009. The medical centre is comprised of 118 departments including the department of medical microbiology and infectious diseases (MMIZ), whose head is Prof. H. Verbrugh. MMIZ itself is divided into 4 units (research and development, diagnostics, infection prevention, and staff) employing 120 people.

The unit research and development (R&D) is headed by Prof. Hubert Endtz, supported by an associate professor (Dr. I. Bakker – Woudenburg), and 5 permanent position researchers of postdoctoral level. There are currently 7 PhD students active in the department and 7 scientific researchers. The main research themes of the unit R&D include: 1) colonisation factors of Staphylococcus aureus, 2) Campylobacter jejuni, molecular mimicry and Guillian-Barré syndrome, 3) the epidemiology and characterisation of antimicrobial resistance, 4) bacterial respiratory pathogens (with special emphasis on Moraxella catarrhalis), 5) models of tuberculosis infection, 6) pathogenicity and antimicrobial resistance of Aspergillus and Madurella fungal pathogens, and 7) the development and validation of ‘rapid’ and ‘Point-Of-Care’ diagnostic technologies for bacterial-mediated diseases.

Dr. J. Hays is coordinator of the TEMPOtest-QC project and is an assistant professor within the unit R&D. He has a special interest in the testing and validation of novel molecular microbial diagnostics, as well as interests in the bacterial pathogen Moraxella catarrhalis (head of organizing committee for ‘HinMax’, a 3-yearly conference for the bacterial pathogens Moraxella catarrhalis and Haemophilus influenzae), as well as antimicrobial resistance in Enterobacteriaceae and Enterococci. The unit R&D has access to (and expertise in) a wide range of molecular research techniques including (whole genome) sequencing, MALDI-Tof, (Real Time) PCR, fluorimetry etc, and is currently developing and validating diagnostic methods associated with RAMAN spectroscopy , ‘electronic nose’ technology, and conventional nucleic acid-based detection technologies.

Finally, MMIZ has participated in several recent national and European-wide (FP6 and FP7), research projects, including DRESP2, OMVac, PILGRIM and now TEMPOtest-QC. The department is always willing to discuss new collaborations and funding opportunities.

7thframeworklogo The TEMPOtest-QC project has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement no 241742 EUFlag
curvebl curvebr